![Clarissa Desjardins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clarissa Desjardins
Directeur/Membre du Conseil chez
INSMED INCORPORATED
Fortune : 8 M $ au 30/06/2026
Profil
Clarissa Desjardins was the founder of Advanced Bioconcept Ltd., founded in 1992, serving as Vice President-Business Development from 1992 to 1998.
Dr. Desjardins was the founder of Caprion Pharmaceuticals, Inc., founded in 1998, serving as Director & Senior VP-Corporate Development from 1998 to 2007.
Dr. Desjardins was the founder of Clementia Pharmaceuticals, Inc., founded in 2011, serving as President, Chief Executive Officer & Director from 2011 to 2019.
Dr. Desjardins is the founder of Congruence Therapeutics, Inc., founded in 2021, serving as Chief Executive Officer since 2021.
Current jobs include Independent Director at Insmed, Inc. since 2019 and Director at Insitut de Recherche en Immunologie et en Cancérologie.
Former jobs include President, Chief Executive Officer & Director at Cepmed from 2009 to 2012; Independent Director at Xenon Pharmaceuticals, Inc.; Director at Genome Canada; Director at La Fondation de l'innovation du Nouveau-Brunswick; and Independent Director at BELLUS Health, Inc. from 2017 to 2023.
Education includes an undergraduate degree conferred in 1992 and a doctorate from McGill University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSMED INCORPORATED 0,03% | 13/05/2026 | 73 337 ( 0,03% ) | 8 M $ | 30/06/2026 |
Postes actifs de Clarissa Desjardins
| Sociétés | Poste | Début |
|---|---|---|
| INSMED INCORPORATED | Directeur/Membre du Conseil | 01/11/2019 |
Congruence Therapeutics, Inc.
 Congruence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Directeur Général | 01/05/2021 |
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Engages in research and development in immunology and cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Clarissa Desjardins
| Sociétés | Poste | Fin |
|---|---|---|
| BELLUS HEALTH | Directeur/Membre du Conseil | 01/07/2023 |
| CLEMENTIA PHARMACEUTICALS INC | Fondateur | 01/04/2019 |
Cepmed | Directeur Général | 01/01/2012 |
La Fondation de l'innovation du Nouveau-Brunswick
 La Fondation de l'innovation du Nouveau-Brunswick Investment ManagersFinance NBIF invests in companies located in Canada. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Directeur/Membre du Conseil | 01/11/2008 |
Caprion Pharmaceuticals, Inc.
 Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovered and developed pharmaceutical products | Fondateur | 01/01/2007 |
Formation de Clarissa Desjardins
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
Caprion Pharmaceuticals, Inc.
Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovered and developed pharmaceutical products | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Advanced Bioconcept Ltd.
 Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Makes proprietary, fluorescent labeled peptids | Electronic Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Provides genomic research services | Commercial Services |
La Fondation de l'innovation du Nouveau-Brunswick
La Fondation de l'innovation du Nouveau-Brunswick Investment ManagersFinance NBIF invests in companies located in Canada. The firm focuses on a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Cepmed | |
Insitut de Recherche en Immunologie et en Cancérologie
Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Engages in research and development in immunology and cancer | Commercial Services |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases | Health Technology |
Congruence Therapeutics, Inc.
Congruence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Choisissez Zonebourse 
